2007: ICON acquired European staffing group, DOCS International.2006: ICON acquired outcomes research and health economics specialist, Ovation Research Group.2004: ICON acquired medical imaging specialist, Beacon Bioscience Inc.2003: ICON acquired Medeval, a UK-based Phase I facility, and US consulting firm, Globomax.2002: ICON acquired clinical research provider, BPA.Central Laboratory in New York and bioanalytical consultancy, Pacific Research 2000: ICON acquired UK-based regulatory consultancy, YRCR Ltd.PRA was acquired by ICON PLC on 1 July 2021. In August 2017, the company acquired Conshohocken-based real-world healthcare data, analytics, and technology solutions company Symphony Health for US$530 million. In 2013 the company was acquired by Kohlberg Kravis Roberts, which brought the company public in November 2014 and maintained shares until September 2019. He had previously been with Quintiles South Africa, Sandoz AG, and Kendle Intl Inc, before joiníng ICON Clinical Research Services in 2011, and becoming Chief Operating Officer in 2014.
In March 2017, Steve Cutler was appointed Chief Executive Officer of ICON. ICON received 2019 Clinical Research Organization leadership awards in five categories, determined by Life Science Leader magazine and Industry Standard Research (ISR). In 2018, ICON won the PharmaTimes Clinical Researcher of the Year. A year later, ICON shares started to be traded on Nasdaq. Lambe retired from the board of directors in 2018.īetween 19, ICON opened offices in the United Kingdom, United States, and Japan. Since January 2010, Climax has held a position on the board of directors. ICON was founded in Dublin, Ireland, by John Climax and Ronan Lambe in 1990. 2 2021 Acquisition of PRA Health Sciences.
0 kommentar(er)
